We are live on ! Find out more
WST icon

West Pharmaceutical

523 hedge funds and large institutions have $15.8B invested in West Pharmaceutical in 2020 Q2 according to their latest regulatory filings, with 118 funds opening new positions, 181 increasing their positions, 165 reducing their positions, and 58 closing their positions.

New
Increased
Maintained
Reduced
Closed

103% more first-time investments, than exits

New positions opened: 118 | Existing positions closed: 58

80% more call options, than puts

Call options by funds: $23.6M | Put options by funds: $13.1M

53% more capital invested

Capital invested by funds: $10.4B → $15.8B (+$5.48B)

50% more funds holding in top 10

Funds holding in top 10: 69 (+3)

12% more funds holding

Funds holding: 468523 (+55)

2.03% more ownership

Funds ownership: 92.08%94.11% (+2%)

10% more repeat investments, than reductions

Existing positions increased: 181 | Existing positions reduced: 165

Holders
523
Holders Change
+55
Holders Change %
+11.75%
% of All Funds
10.72%
Holding in Top 10
9
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+50%
% of All Funds
0.18%
New
118
Increased
181
Reduced
165
Closed
58
Calls
$23.6M
Puts
$13.1M
Net Calls
+$10.5M
Net Calls Change
+$3.36M
Name Holding Trade Value Shares
Change
Change in
Stake
GT
251
Glenmede Trust
Pennsylvania
$1.57M -$1.45M -7,382 -52%
SAM
252
Securian Asset Management
Minnesota
$1.57M -$148K -751 -10%
Wealth Enhancement Advisory Services
253
Wealth Enhancement Advisory Services
Minnesota
$1.54M +$1.18M +6,021 New
JIC
254
Johnson Investment Counsel
Ohio
$1.54M -$184K -935 -12%
Rafferty Asset Management
255
Rafferty Asset Management
New York
$1.5M +$1.3M +6,606 New
American Century Companies
256
American Century Companies
Missouri
$1.48M +$630K +3,206 +96%
AC
257
Allstate Corporation
Illinois
$1.47M -$10.4K -53 -0.8%
Jennison Associates
258
Jennison Associates
New York
$1.47M +$1.27M +6,453 New
SAM
259
Silvercrest Asset Management
New York
$1.43M +$16.7K +85 +1%
CIBC Asset Management
260
CIBC Asset Management
Ontario, Canada
$1.43M +$703K +3,577 +132%
EF
261
Empowered Funds
Pennsylvania
$1.39M +$1.2M +6,120 New
BB
262
Bell Bank
North Dakota
$1.39M -$11.8K -60 -1%
NB
263
Norinchukin Bank
Japan
$1.39M +$1.2M +6,101 New
NEI
264
Northwest & Ethical Investments
Ontario, Canada
$1.38M +$1.19M +6,080 New
VCM
265
Virtue Capital Management
Tennessee
$1.37M +$1.19M +6,033 New
HA
266
Harfst & Associates
Wyoming
$1.36M -$68K -346 -5%
SCP
267
Syntal Capital Partners
Texas
$1.35M +$1.17M +5,958 New
II
268
IFM Investors
Australia
$1.23M -$476K -2,425 -31%
RIM
269
Rampart Investment Management
Connecticut
$1.22M +$1.06M +5,371 New
Fifth Third Bancorp
270
Fifth Third Bancorp
Ohio
$1.2M -$6.09K -31 -0.6%
WCM
271
Weld Capital Management
New York
$1.19M +$1.02M +5,215 New
CC
272
Cipher Capital
New York
$1.18M +$659K +3,355 +181%
O
273
Ossiam
France
$1.16M +$1M +5,099 New
NMERB
274
New Mexico Educational Retirement Board
New Mexico
$1.14M -$2.48M -12,632 -72%
GC
275
Globeflex Capital
California
$1.13M +$59.9K +305 +7%

WST Hedge Fund Activity: Q2 2020 in Review

523 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q2 2020, worth a combined $15.8B — up 53% from $10.4B a quarter earlier.

Buyers outnumbered sellers: 118 funds opened new WST positions and 58 closed out — a net gain of 60 holders — while 181 added to existing stakes and 165 trimmed.

The largest buyer was Vanguard Group, adding an estimated $184M. The largest seller was BlackRock, cutting an estimated $351M.

  • 523 institutional investors held West Pharmaceutical (WST) as of Q2 2020, up from 468 in Q1 2020.
  • Funds reported $15.8B of West Pharmaceutical stock for Q2 2020, up 53% quarter-over-quarter.
  • 118 funds opened new West Pharmaceutical positions in Q2 2020 and 58 closed out, a net change of +60 holders.
  • The largest West Pharmaceutical buyer in Q2 2020 was Vanguard Group, an estimated $184M added.
  • The largest West Pharmaceutical seller in Q2 2020 was BlackRock, an estimated $351M sold.

Based on aggregated 13F filings for Q2 2020.